文献速递青光眼眼底病与葡萄膜炎

拉坦前列素布诺德与噻吗洛尔对视网膜血管密度影响的比较:一项随机临床试验

Comparison of the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density: A Randomized Clinical Trial.
PubMed 文献 · Am J Ophthalmol · 2022-05-06

这项随机、单中心、交叉临床试验比较了0.024%拉坦前列素布诺德(LBN)每日一次与0.5%马来酸噻吗洛尔每日两次对开角型青光眼(OAG)或高眼压症(OHT)患者及正常人视网膜血管密度(VD)的影响。结果显示,OAG/OHT患者使用LBN后黄斑VD显著增加,而使用噻吗洛尔后黄斑VD无变化,仅鼻下扇区视盘周围VD降低;正常人两种药物均未引起VD变化。

要点

  • OAG/OHT患者使用LBN后黄斑VD显著增加(0.76% [0.20%-1.33%],P=0.009)。
  • OAG/OHT患者使用噻吗洛尔后黄斑VD无差异,仅鼻下扇区视盘周围VD降低(-0.56% [-1.08%至-0.03%],P=0.04)。
  • 正常人使用LBN或噻吗洛尔后视盘周围及黄斑VD均无变化(P>0.05)。

核心结论

  • 局部使用LBN可增强OAG或OHT患者的黄斑VD,而噻吗洛尔对VD无任何影响。

研究设计与样本

  • 随机、单中心、交叉临床试验,纳入50例受试者(10例健康者、26例OHT患者、14例OAG患者),每例取一只眼入组。
  • 受试者按1:1随机分配至LBN每日一次或噻吗洛尔每日两次,双眼用药,每种药物治疗4周,中间间隔2周洗脱期,共12周内完成6次访视。

主要发现

  • OAG/OHT患者使用LBN后黄斑VD显著增加(0.76% [0.20%-1.33%],P=0.009),视盘周围VD有增加趋势。
  • OAG/OHT患者使用噻吗洛尔后黄斑VD无差异,仅鼻下扇区视盘周围VD降低(-0.56% [-1.08%至-0.03%],P=0.04)。
  • 正常受试者使用LBN或噻吗洛尔后视盘周围及黄斑VD均无变化(P>0.05)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the differences in retinal vessel density (VD) between topical administration of latanoprostene bunod (LBN) ophthalmic solution 0.024% and timolol maleate 0.5% in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT) and normal subjects. DESIGN: Randomized, single center, crossover clinical trial. METHODS: Eligible subjects were examined during 6 study visits over 12 weeks. All subjects were randomized in a 1:1 ratio to LBN dosed once daily or timolol dosed twice daily in both eyes (OU) for a duration of 4 weeks each, separated by a 2-week washout period. A comprehensive eye examination OU was performed at each visit. Testing was performed with optical coherence tomography and optical coherence tomography angiography (optic nerve and macula), as well as visual field examination, on the study eye at baseline and before and after each treatment. RESULTS: One eye from each of 50 patients was enrolled (10 healthy patients, 26 patients with OHT, and 14 patients with OAG). After administration of LBN there was significantly increased macular VD (0.76% [0.20%-1.33%], P = 0.009) and a trend in increasing peripapillary VD in patients with OAG and patients with OHT. In contrast, after administration of timolol, there were no differences in macular VD, and a decrease in peripapillary VD only was observed in the nasal inferior sector (-0.56% [-1.08% to -0.03%], P = .04) in patients with OAG and patients with OHT. No change in peripapillary or macular VD was observed in the normal subjects (P > .05 for all). CONCLUSIONS: Topical administration of LBN enhanced macular VD in patients with OAG or patients with OHT. In contrast, timolol administration did not have any effect on VD.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. El-Nimri NW, Moghimi S, Penteado RC, et al. Comparison of the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density: A Randomized Clinical Trial. Am J Ophthalmol. 2022. PMID: 35526590. doi:10.1016/j.ajo.2022.04.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。